TORRENT PHARMACEUTICALS
Back to Income Statement
|
TORRENT PHARMACEUTICALS Last 5 Year Profit After Tax History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Profit After Tax | ₹1,656 Cr | ₹1,245 Cr | ₹777 Cr | ₹1,252 Cr | ₹1,025 Cr |
What is the latest Profit After Tax of TORRENT PHARMACEUTICALS ?
| Year | Profit After Tax |
|---|---|
| Mar2025 | ₹1,656 Cr |
| Mar2024 | ₹1,245 Cr |
| Mar2023 | ₹777 Cr |
| Mar2022 | ₹1,252 Cr |
| Mar2021 | ₹1,025 Cr |
How is Profit After Tax of TORRENT PHARMACEUTICALS Trending?
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,656 Cr | 33.02 | |
| Mar2024 | ₹1,245 Cr | 60.22 | |
| Mar2023 | ₹777 Cr | -37.92 | |
| Mar2022 | ₹1,252 Cr | 22.17 | |
| Mar2021 | ₹1,025 Cr | - | |
Compare Profit After Tax of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹131,463.3 Cr | 2.4% | 4.5% | 14.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹414,929.0 Cr | 0.7% | -4.2% | -8.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,918.0 Cr | 0% | -1% | 4% | Stock Analytics | |
| CIPLA | ₹122,725.0 Cr | 1.1% | 0.2% | -1.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,224.0 Cr | -1% | -2% | -9.7% | Stock Analytics | |
| MANKIND PHARMA | ₹90,922.4 Cr | 1% | -0.2% | -24.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | 2.4% |
4.5% |
14.5% |
| SENSEX | 0.9% |
0.7% |
9.6% |
You may also like the below Video Courses